This study is evaluating whether a drug may help improve blood flow in the skin of black individuals.
2 Primary · 0 Secondary · Reporting Duration: Through study completion, an average of 1 Year
50 Total Participants · 4 Treatment Groups
Primary Treatment: Norepinephrine + Ascorbic Acid · No Placebo Group · Phase 1
Participation is compensated
You will be compensated for participating in this trial.
Age 18 - 35 · All Participants · 2 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: